McKesson ROA 2010-2024 | MCK

Current and historical return on assets (ROA) values for McKesson (MCK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
McKesson ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $2.83B $71.08B 4.00%
2024-09-30 $2.54B $72.43B 3.65%
2024-06-30 $2.96B $71.67B 4.36%
2024-03-31 $3.00B $67.44B 4.55%
2023-12-31 $3.00B $66.51B 4.63%
2023-09-30 $3.49B $66.09B 5.47%
2023-06-30 $3.75B $64.10B 5.95%
2023-03-31 $3.56B $62.32B 5.69%
2022-12-31 $3.14B $62.69B 5.00%
2022-09-30 $2.06B $63.08B 3.26%
2022-06-30 $1.40B $62.30B 2.21%
2022-03-31 $1.11B $63.30B 1.76%
2021-12-31 $1.41B $63.71B 2.21%
2021-09-30 $-4.81B $63.60B -7.59%
2021-06-30 $-4.50B $62.89B -7.16%
2021-03-31 $-4.54B $65.02B -7.38%
2020-12-31 $-4.18B $61.85B -6.91%
2020-09-30 $2.23B $61.56B 3.69%
2020-06-30 $0.92B $57.67B 1.54%
2020-03-31 $0.90B $61.25B 1.48%
2019-12-31 $-0.92B $60.87B -1.52%
2019-09-30 $-0.63B $58.99B -1.05%
2019-06-30 $0.60B $61.68B 0.98%
2019-03-31 $0.03B $59.67B 0.06%
2018-12-31 $-0.32B $61.01B -0.52%
2018-09-30 $0.12B $61.42B 0.19%
2018-06-30 $-0.38B $61.28B -0.61%
2018-03-31 $0.07B $60.38B 0.11%
2017-12-31 $4.80B $64.21B 7.66%
2017-09-30 $4.53B $63.85B 7.41%
2017-06-30 $4.84B $61.82B 8.10%
2017-03-31 $5.07B $60.97B 8.63%
2016-12-31 $1.91B $57.87B 3.32%
2016-09-30 $1.91B $58.32B 3.36%
2016-06-30 $2.22B $57.90B 3.95%
2016-03-31 $2.26B $56.52B 4.04%
2015-12-31 $1.96B $55.09B 3.55%
2015-09-30 $1.80B $55.82B 3.26%
2015-06-30 $1.65B $55.93B 3.04%
2015-03-31 $1.48B $53.87B 2.76%
2014-12-31 $1.71B $55.11B 3.23%
2014-09-30 $1.31B $52.23B 2.70%
2014-06-30 $1.24B $53.01B 2.80%
2014-03-31 $1.26B $51.76B 3.16%
2013-12-31 $1.15B $36.48B 3.23%
2013-09-30 $1.39B $35.95B 3.97%
2013-06-30 $1.38B $35.49B 4.04%
2013-03-31 $1.34B $34.79B 4.03%
2012-12-31 $1.60B $33.43B 4.88%
2012-09-30 $1.60B $32.97B 4.89%
2012-06-30 $1.50B $31.75B 4.61%
2012-03-31 $1.40B $33.09B 4.34%
2011-12-31 $1.30B $33.16B 4.11%
2011-09-30 $1.16B $31.91B 3.73%
2011-06-30 $1.19B $31.02B 4.00%
2011-03-31 $1.20B $30.89B 4.16%
2010-12-31 $1.13B $30.40B 4.00%
2010-09-30 $1.30B $26.79B 4.73%
2010-06-30 $1.27B $27.40B 4.64%
2010-03-31 $1.26B $28.19B 4.67%
2009-12-31 $1.20B $27.54B 4.55%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $84.343B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.771B 16.47
Cardinal Health (CAH) United States $33.281B 17.82
Labcorp (LH) United States $19.480B 15.97
Straumann Holding AG (SAUHY) Switzerland $19.198B 0.00
Cooper (COO) United States $16.868B 22.37
West Pharmaceutical Services (WST) United States $16.185B 33.17
Align Technology (ALGN) United States $11.630B 22.53
Henry Schein (HSIC) United States $8.505B 14.45
Merit Medical Systems (MMSI) United States $6.219B 30.38
DENTSPLY SIRONA (XRAY) United States $2.973B 8.95
Patterson (PDCO) United States $2.764B 15.94
CONMED (CNMD) United States $1.867B 14.52
STAAR Surgical (STAA) United States $0.870B 0.00
Lifevantage (LFVN) United States $0.183B 20.25
Pro-Dex (PDEX) United States $0.162B 24.67